The science
BioCell Collagen is hydrolyzed type II collagen bound to hyaluronic acid and chondroitin sulfate — the same three molecules that make cartilage and the dermis. Multiple human trials. Seven U.S. and international patents.
How it works
Researchers isolated a cartilage matrix of type II collagen, hyaluronic acid, and chondroitin sulfate that closely resembles human articular cartilage. A patented hydrolysis process brings the molecular weight down to about 1.5–2 kDa — versus 200–300 kDa for undenatured collagen that the gut barely handles.
In liquid form, absorption can begin in the mouth, skipping the long first-pass the powder still has to make. The same matrix deactivates hyaluronidase, the enzyme that tears hyaluronic acid down. That is why a bioavailability study saw steady-state HA rise as much as sixty-fold.
Delivery
Not all collagen
| BioCell Collagen (hydrolyzed) | Undenatured type II | |
|---|---|---|
| Collagen form | Type II, hydrolyzed | Type II, unhydrolyzed |
| Hyaluronic acid & chondroitin | Yes | Unclear / not substantial |
| Molecular weight | 1.5–2.5 kDa | 200–300 kDa |
| Efficient absorption | Yes | Unclear |
| Clinical HA bioavailability | About 60-fold increase | Not shown |
| Chondrocyte stimulation | Yes | No |
| Hyaluronidase inhibition | Yes | Unclear |
| Human studies | Joints and skin | Joints |
Human studies
joints
89% reported improved joint comfort
Eighty-nine subjects with joint discomfort ingested 2 g of BioCell Collagen daily for 45 days. Eighty subjects (89%) experienced improved joint comfort. One placebo subject improved. No adverse events associated with BioCell Collagen.
Human trial, 89 subjects
joints
Up to 40% less discomfort vs placebo
Randomized, double-blind, placebo-controlled trial in 16 subjects. 2 g daily for 8 weeks. BioCell Collagen significantly reduced joint discomfort by as much as 40% compared with placebo, using the WOMAC index.
Experimental Biology, 2004
joints
71% had at least 30% less discomfort
Randomized, double-blind, placebo-controlled trial in 80 subjects. 2 g daily for 10 weeks. Confirmed the earlier WOMAC result. No adverse events associated with BioCell Collagen.
Journal of Agricultural and Food Chemistry, 2012
Read the paperjoints
Clinically meaningful improvements vs placebo
Placebo-controlled eight-week pilot in sixteen adults with osteoarthritis (Sheldon, Miami Research Associates, 2003). BioCell Collagen II was superior to placebo on a standard OA symptom tool, without a greater incidence of side effects.
Sheldon, E. Miami Research Associates, 2003
skin
Fewer lines, less dryness, more dermal collagen
Twenty-six subjects undergoing natural and photoaging took 1 g daily for 12 weeks. Measurements included wrinkles, fine lines, dermal collagen, hydration, and microcirculation. BioCell Collagen reduced facial lines and wrinkles, reduced dryness and scaling, and increased collagen content in the dermis. No adverse events.
Clinical Interventions in Aging, 2012
Read the paperbioavailability
Up to a 60-fold increase in steady-state HA
In a 36-hour single-dose study, HA in blood peaked more than 7000% above control at twelve hours. In a 28-day daily-dose study, steady-state HA reached about 3500% above control and an HA metabolite more than 11,000% above control. Subjects taking Liquid BioCell (1500 mg/day) for 28 days increased steady-state HA as much as 60-fold. The matrix also deactivates hyaluronidase, the enzyme that breaks HA down.
Judy, W. SIBR, 2004 · HA follow-on in Liquid BioCell
recovery
Lower stress markers, less performance drop
Blood markers associated with muscular stress (creatine kinase, lactate dehydrogenase, C-reactive protein) improved versus placebo after exercise challenges. Post-challenge performance decrement was diminished in the BioCell Collagen group.
Journal of the International Society of Sports Nutrition
Read the papersafety
Well tolerated at all doses studied
Two oral toxicity studies in rats of hydrolyzed chicken sternal cartilage (collagen type II, chondroitin sulfate, hyaluronic acid). Acute 5000 mg/kg: all survived, normal weight gain, no gross lesions. Subchronic 30, 300, and 1000 mg/kg for 90 days: all survived; differences were not dose-related or toxicologically significant.
Schauss et al., Food and Chemical Toxicology, 2007
Questions we get
Almost never. Most powders are type I collagen from hide or fish, dosed around 10 grams, without meaningful hyaluronic acid or chondroitin. BioCell Collagen is hydrolyzed type II from cartilage — the collagen of joints — naturally bound to HA and chondroitin, at a patented low molecular weight, in a clinical dose of 1–2 grams.
The matrix was first a powder. A liquid delivery means absorption can begin in the mouth and does not have to wait on binders, fillers, or a long trip through first-pass metabolism. Liquids are also easier for people who do not like swallowing horse-pills. The clinical work is on the matrix itself; the liquid is how we prefer to get it in.
Skin hydration and the feel of joints often shift in a few weeks. Published joint trials ran 8–10 weeks; the facial-aging study ran 12. Give it a full three months. Individual results vary.
A minimum of two bottles a month for three months. That is the honest protocol — not one bottle to try and stop. Call if you want help matching a formula.
Adults who feel connective tissue aging: stairs, tennis, running, a face that looks drier than it feels. Athletes who have used their joints up. Anyone tired of powders that do not match cartilage. If you are pregnant, nursing, or under medical care, talk to your physician first.